ReferIndia News Arfin India Limited Approves ₹4.5 Crore Investment in Subsidiary's Rights Issue

ReferIndia News

Dr. Aditya Manke

Dr. Aditya Manke — Expert Robotic & Laparoscopic Cancer Surgeon. Precise care, faster recovery.

Contact Now
News Image

Arfin India Limited Approves ₹4.5 Crore Investment in Subsidiary's Rights Issue

Published on: March 14, 2026, 11:44 a.m. | Source: scanx.trade

Arfin India Limited's board approved subscription to rights issue of wholly owned subsidiary Arfin Titanium & Speciality Alloys Limited for up to ₹4.5 crore on March 14, 2026. The investment aims to fund business operations and growth of the subsidiary, which operates in non-ferrous metal manufacturing and was incorporated on January 14, 2025. The transaction is a related party deal conducted at arm's length, requiring no regulatory approvals.

Checkout more news
Ad Banner

Grow. Protect. Prosper.

Your wealth deserves expert care. Our advisors craft personalized investment plans designed to grow and safeguard your assets.

Schedule Call
ReferIndia News contact